MARK M MEDEIROS

Allopathic & Osteopathic Physicians|Family Medicine SCOTTSDALE, AZ NPI 1679570832

General Payments — all program years on this page

$1,703.41

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 87
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $318.47 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $318.4719

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $396.9626
2019 $389.1921
2020 $70.074
2022 $194.535
2023 $334.1912
2024 $318.4719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087105072 Novartis Pharmaceuticals Corporation $13.82 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087105074 Novartis Pharmaceuticals Corporation $16.41 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097577948 Novo Nordisk Inc $16.20 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097715815 Novo Nordisk Inc $18.37 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101295763 E.R. Squibb & Sons, L.L.C. $13.29 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104222197 AstraZeneca Pharmaceuticals LP $16.41 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104391211 AstraZeneca Pharmaceuticals LP $13.18 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104532808 AstraZeneca Pharmaceuticals LP $14.66 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104556948 AstraZeneca Pharmaceuticals LP $19.32 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104639289 AstraZeneca Pharmaceuticals LP $13.37 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105013113 ABBVIE INC. $16.75 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105391359 AstraZeneca Pharmaceuticals LP $20.87 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105553142 AstraZeneca Pharmaceuticals LP $14.80 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111649112 Amgen Inc. $16.99 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111649114 Amgen Inc. $16.08 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118106885 Boehringer Ingelheim Pharmaceuticals, Inc. $20.97 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135168490 Lilly USA, LLC $18.59 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145945340 Lundbeck LLC $19.77 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145945342 Lundbeck LLC $18.62 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.